These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38369325)

  • 21. Induced pluripotent stem cell technology: a decade of progress.
    Shi Y; Inoue H; Wu JC; Yamanaka S
    Nat Rev Drug Discov; 2017 Feb; 16(2):115-130. PubMed ID: 27980341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotrophic Factors Secreted by Induced Pluripotent Stem Cell-Derived Retinal Progenitors Promote Retinal Survival and Preservation in an Adult Porcine Neuroretina Model.
    Rettinger CL; Kaini RR; Burke TA; Wang HC
    J Ocul Pharmacol Ther; 2021 Jun; 37(5):301-312. PubMed ID: 33661042
    [No Abstract]   [Full Text] [Related]  

  • 24. Current Development, Obstacle and Futural Direction of Induced Pluripotent Stem Cell and Mesenchymal Stem Cell Treatment in Degenerative Retinal Disease.
    Chiang MC; Chern E
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pluripotent stem cell applications for regenerative medicine.
    Angelos MG; Kaufman DS
    Curr Opin Organ Transplant; 2015 Dec; 20(6):663-70. PubMed ID: 26536430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogrammed cells for disease modeling and regenerative medicine.
    Cherry AB; Daley GQ
    Annu Rev Med; 2013; 64():277-90. PubMed ID: 23327523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.
    Kramer AS; Harvey AR; Plant GW; Hodgetts SI
    Cell Transplant; 2013; 22(4):571-617. PubMed ID: 22944020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New advances in stem cell research: practical implications for regenerative medicine.
    Ratajczak MZ; Jadczyk T; Pędziwiatr D; Wojakowski W
    Pol Arch Med Wewn; 2014; 124(7-8):417-26. PubMed ID: 24956404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell transplantation for spinal cord injury focusing on iPSCs.
    Nakamura M; Tsuji O; Nori S; Toyama Y; Okano H
    Expert Opin Biol Ther; 2012 Jul; 12(7):811-21. PubMed ID: 22519931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges.
    Maeda T; Mandai M; Sugita S; Kime C; Takahashi M
    Trends Mol Med; 2022 May; 28(5):388-404. PubMed ID: 35370091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous stem cell therapy for inherited and acquired retinal disease.
    Apatoff MBL; Sengillo JD; White EC; Bakhoum MF; Bassuk AG; Mahajan VB; Tsang SH
    Regen Med; 2018 Jan; 13(1):89-96. PubMed ID: 29360008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
    Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Future prospects for regenerated heart using induced pluripotent stem cells.
    Fujita J; Fukuda K
    J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report.
    Fortress AM; Miyagishima KJ; Reed AA; Temple S; Clegg DO; Tucker BA; Blenkinsop TA; Harb G; Greenwell TN; Ludwig TE; Bharti K
    Stem Cell Res Ther; 2023 Mar; 14(1):53. PubMed ID: 36978104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult stem cells: hopes and hypes of regenerative medicine.
    Dulak J; Szade K; Szade A; Nowak W; Józkowicz A
    Acta Biochim Pol; 2015; 62(3):329-37. PubMed ID: 26200199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steps toward safe cell therapy using induced pluripotent stem cells.
    Okano H; Nakamura M; Yoshida K; Okada Y; Tsuji O; Nori S; Ikeda E; Yamanaka S; Miura K
    Circ Res; 2013 Feb; 112(3):523-33. PubMed ID: 23371901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reprogramming of Keratinocytes as Donor or Target Cells Holds Great Promise for Cell Therapy and Regenerative Medicine.
    Zhang Y; Hu W; Ma K; Zhang C; Fu X
    Stem Cell Rev Rep; 2019 Oct; 15(5):680-689. PubMed ID: 31197578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates in regenerative medicine applied to dental sciences.
    Pacifici A; Polimeni A; Pacifici L
    J Biol Regul Homeost Agents; 2018; 32(5):1275-1278. PubMed ID: 30334425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.